Data

The Study for Mother-Infant Sleep (The SMILE Project): Reducing postpartum insomnia in first-time mothers.

Monash University

Dataset description

A provisional psychologist trained in the study protocol under the supervision of a clinical psychologist, will interact with participants in the three intervention conditions via phone to personalise interventions, providing recommendations of certain modules through an orientation phone call which will take up to 90 minutes. Participants will be randomised into 1 of 3 conditions: (a) an infant sleep intervention, (b) a maternal sleep intervention, and (c) a control condition.
Group A: Participants in the infant sleep intervention condition will be asked to use a responsive bassinet from birth until their infant reaches 6 months postpartum. The bassinet (a) automatically emits white-noise sounds, (b) safely swaddles the infant, which is recommended by the American Academy of Pediatrics (APP) as the safest sleeping position for the prevention of Sudden Infant Death Syndrome, and (c) provides rhythmic ‘rocking’ motions when crying noises are detected. Importantly, the bassinet employs these strategies for a maximum of 3 minutes. If the infant does not settle within this time, the bassinet alerts adults for additional assistance via a mobile application (e.g., feeding, changing). Use of the responsive bassinet and mobile application will be measured using an Intervention Adherence and Usefulness questionnaire delivered at 8 weeks and 6 months postpartum to examine roles in treatment response. Bassinet status/usage data will also be collected using the mobile application.
Group B: The maternal sleep condition uses therapist-assisted self-help cognitive behavioural therapy for insomnia (CBT-I) to address maladaptive sleep-related cognitions and behaviours. Content of the intervention is delivered via the following three means, combined: (1) A 50-minute telephone session conducted by a provisional psychologist; (2) A series of emails containing text, graphics, and/or audio-based intervention components are delivered at 6 stages: 30 weeks and 35 weeks pregnancy, then 2 weeks, 2 months, 3 months, and 6 months postpartum. Each email will address a specific component of sleep disturbance relevant to women in the perinatal period (e.g. developing healthy sleep habits) via text and images, and may include links to audio-based mindfulness and relaxation exercises. All participants in Group B will receive the same emails, which have been specifically designed for this study. (3) Mothers who have difficulty applying the intervention materials can request brief email or telephone clarification from the provisional psychologist who conducted the initial session. Treatment adherence will be measured using an Intervention Adherence and Usefulness questionnaire delivered at 35-36 weeks of gestation, and 8 weeks and 6 months postpartum.
Treatment effects will be assessed at 5 time points: 26-32 weeks of gestation (T1), 35-36 weeks of gestation (T2), 8 weeks postpartum (T3), 6 months postpartum (T4), and 12 months postpartum (T5).
Click to explore relationships graph

Source Study

Trial acronym

SMILE

Trial ID

ACTRN12619001166167

Purpose

Treatment

Phase

Not Applicable

Funding

University,Monash University Graduate Research Student Funding/Developmental Research Funding

Scientific enquiries

Dr Bei Bei

Brief Summary

Symptoms of insomnia are common for women in the perinatal period. A primary precipitating factor for postpartum insomnia is infant nocturnal awakenings. As women cope with these significant sleep disruptions, they may also develop unhelpful sleep-related cognitions/behaviours, which can perpetuate sleep problems well into the postpartum period. Therefore, (a) infant sleep as a precipitator, and (b) maternal sleep-related cognitions and behaviours as perpetuators are sound therapeutic targets fo ....
Read more

Key Inclusion Criteria

Inclusion criteria: (a) Nulliparous mothers in the 3rd trimester of pregnancy (i.e., 26-32 weeks gestation and no older children). (b) Singleton pregnancy; (c) Age >= 18 years. (d) Able to read and write in English. (e) Have regular access to a smartphone, email, and internet. (f) Score > 7 on the Insomnia Severity Index (ISI; Bastien, Vallières, & Morin, 2001).

Key Exclusion Criteria

(a) Participants who use medications or substance that directly effect sleep (including sleep medications, melatonin, steroid inhalers, antidepressant medications, cannabis, etc.) (b) Unstable medical conditions that directly affect sleep; (c) Participants who show the following symptoms of sleep disorders: a. Sleep apnea: loud snoring OR observed gasping or pauses in breathing OR previously diagnosed with apnea hypopnea index >15 but not/inadequately treated b. Previously diagnosed Periodic Lim ....
Read more

Can healthy volunteers participate?

No

 

Population

Sample Size    127

Min. age    18 Years

Max. age    No limit

Sex    Females

Condition category    Insomnia , Sleep disturbance

Condition code    Mental Health , Neurological , Reproductive Health and Childbirth

Intervention

Intervention code Behaviour , Treatment: Devices

A provisional psychologist trained in the study protocol under the supervision of a clinical psychologist, will interact with participants in the three intervention conditions via phone to personalise interventions, providing recommendations of certain modules through an orientation phone call which will take up to 90 minutes. Participants will be randomised into 1 of 3 conditions: (a) an infant sleep intervention, (b) a maternal sleep intervention, and (c) a control condition. Group A: Particip ....
Read more

Comparison

Control group Active

Group C: Participants in the control condition will receive an information booklet at 30 weeks pregnancy containing the psychoeducation and sleep hygiene information from the maternal sleep intervention without other components. The information booklet has been designed specifically for this study. This condition will account for the non-specific effects of attention and participation in a sleep program (e.g., contact with health professionals, receiving health information, and expectations of b ....
Read more

Outcomes

Outcome: Maternal insomnia symptoms measured via Insomnia Severity Index (ISI; Bastien, Vallières, & Morin, 2001).
Timepoint: The ISI will be assessed at 5 time points: 26-32 weeks of gestation (T1), 35-36 weeks of gestation (T2), 8 weeks postpartum (T3), 6 months postpartum (T4), and 12 months postpartum (T5). The average ISI across T3-T5 will be used as the primary timepoint, as well as postpartum endpoint. As shown in previous data, sleep undergoes major changes during ....

Read more

Study Protocol: Not Available
Data Dictionary: Not Available

Will individual participant data (IPD) for this trial be available?

yes

What data in particular will be shared?

The research database will be made publicly available 7 years after the final publication, although we will de-identify the data by removing names, date of birth, addresses/contact details, and any information that may link the data to individual participants. These personally identifying data will be completely erased and destroyed.

When will data be available?

Data will be available 7 years after the final publication. No end date.

Available to whom?

The de-identified database will be made available through Monash Figshare to maximize the potential benefit to the scientific and research community. Monash Figshare is a collaborative digital repository for Monash University researchers. Access is restricted to Monash researchers and graduate research students only.

Available for what types of analyses?

Any purpose.

Source study information is derived from the Australian New Zealand Clinical Trials Registry (ANZCTR). For more information on the ANZCTR, please see anzctr.org.au